No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Drug Administration Schedule
-
Humans
-
Immunologic Factors / therapeutic use*
-
Multiple Sclerosis / therapy*
-
Natalizumab
-
Randomized Controlled Trials as Topic
-
Secondary Prevention
-
United States
Substances
-
Antibodies, Monoclonal, Humanized
-
Immunologic Factors
-
Natalizumab